Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review

Since December 2019, the COVID-19 pandemic has become a major public health problem. To date, there is no evidence of a higher incidence of COVID in patients with autoimmune rheumatic diseases and we support the approach of maintaining chronic rheumatological treatments. However, once infected there...

Descripción completa

Detalles Bibliográficos
Autores principales: Grange, Lucile, Guilpain, Philippe, Truchetet, Marie-Elise, Cracowski, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320663/
https://www.ncbi.nlm.nih.gov/pubmed/32665090
http://dx.doi.org/10.1016/j.therap.2020.06.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320663/
https://www.ncbi.nlm.nih.gov/pubmed/32665090
http://dx.doi.org/10.1016/j.therap.2020.06.013

Ejemplares similares